Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · IEX Real-Time Price · USD
2.580
-0.020 (-0.77%)
At close: Mar 28, 2024, 4:00 PM
2.610
+0.030 (1.16%)
After-hours: Mar 28, 2024, 5:46 PM EDT
Arbutus Biopharma Market Cap
Arbutus Biopharma has a market cap or net worth of $465.05 million as of March 28, 2024. Its market cap has decreased by -5.59% in one year.
Market Cap
465.05M
Enterprise Value
340.81M
1-Year Change
-5.59%
Ranking
Category
Stock Price
$2.58
Market Cap Chart
Since December 31, 2009, Arbutus Biopharma's market cap has increased from $47.50M to $465.05M, an increase of 879.04%. That is a compound annual growth rate of 17.37%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 466.70M | 4.43% |
Mar 26, 2024 | 446.90M | - |
Mar 25, 2024 | 446.90M | -0.40% |
Mar 22, 2024 | 448.70M | -1.97% |
Mar 21, 2024 | 457.70M | - |
Mar 20, 2024 | 457.70M | 2.01% |
Mar 19, 2024 | 448.70M | -1.58% |
Mar 18, 2024 | 455.90M | -3.06% |
Mar 15, 2024 | 470.30M | 0.38% |
Mar 14, 2024 | 468.50M | -3.32% |
Mar 13, 2024 | 484.60M | 0.37% |
Mar 12, 2024 | 482.80M | -1.11% |
Mar 11, 2024 | 488.20M | -0.37% |
Mar 8, 2024 | 490.00M | 1.11% |
Mar 7, 2024 | 484.60M | -1.46% |
Mar 6, 2024 | 491.80M | 2.63% |
Mar 5, 2024 | 479.20M | 5.43% |
Mar 4, 2024 | 454.50M | -2.86% |
Mar 1, 2024 | 467.90M | -0.34% |
Feb 29, 2024 | 469.50M | -2.80% |
Feb 28, 2024 | 483.00M | -1.37% |
Feb 27, 2024 | 489.70M | - |
Feb 26, 2024 | 489.70M | - |
Feb 23, 2024 | 489.70M | 0.35% |
Feb 22, 2024 | 488.00M | 1.04% |
View and export this data all the way back to 2009.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
iTeos Therapeutics | 473.13M |
Akebia Therapeutics | 472.13M |
Replimune Group | 472.07M |
P3 Health Partners | 471.67M |
Aveanna Healthcare Holdings | 471.33M |
KalVista Pharmaceuticals | 465.34M |
Entrada Therapeutics | 462.35M |
ETAO International Co. | 461.01M |